CCOJF(CCOJF)
CCOJF
No analyst ratings available
No analyst price targets available for CCOJF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $915.89B | $925.87B | $936.33B | $914.67B | $918.70B |
| Low | $903.57B | $903.37B | $918.62B | $897.38B | $901.33B |
| High | $925.66B | $943.56B | $950.28B | $928.30B | $932.39B |
| EBITDA Avg | $71.26B | $79.22B | $86.56B | $89.51B | $96.85B |
| Low | $70.48B | $78.23B | $85.38B | $88.24B | $95.39B |
| High | $71.87B | $80.00B | $87.49B | $90.51B | $97.99B |
| EBIT Avg | $32.48B | $41.10B | $48.88B | $52.36B | $60.08B |
| Low | $31.70B | $40.11B | $47.70B | $51.09B | $58.62B |
| High | $33.10B | $41.88B | $49.81B | $53.35B | $61.22B |
| Net Income Avg | $25.04B | $31.85B | $37.99B | $40.74B | $46.84B |
| Low | $24.42B | $31.07B | $37.06B | $39.74B | $45.69B |
| High | $25.52B | $32.47B | $38.73B | $41.53B | $47.75B |
| EPS Avg | $146.25 | $186.04 | $221.93 | $237.96 | $273.58 |
| Low | $142.65 | $181.46 | $216.48 | $232.11 | $266.86 |
| High | $149.08 | $189.64 | $226.23 | $242.57 | $278.89 |
| Analysts (Rev / EPS) | 10 / 1 | 10 / 1 | 4 / 1 | 5 / 1 | 5 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $272.83B | $213.25B |
| Low | $271.05B | $208.88B |
| High | $275.89B | $216.24B |
| EBITDA Avg | $29.70B | $12.66B |
| Low | $29.34B | $12.58B |
| High | $30.05B | $12.74B |
| EBIT Avg | $22.18B | $5.11B |
| Low | $21.82B | $5.03B |
| High | $22.53B | $5.19B |
| Net Income Avg | $17.31B | $3.83B |
| Low | $17.03B | $3.76B |
| High | $17.59B | $3.89B |
| EPS Avg | $104.40 | $23.08 |
| Low | $102.68 | $22.70 |
| High | $106.09 | $23.45 |
| Analysts (Rev / EPS) | 3 / 1 | 3 / 1 |